Drug news
The Medicines Company to co promote Promus Premier cardiac stent in US-Boston Scientific
Boston Scientific Corporation and The Medicines Company announced a co-promotion agreement for the Boston Scientific Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System. Under the terms of the agreement, The Medicines Company's acute cardiovascular care sales force will collaborate with the Boston Scientific Interventional Cardiology sales force to provide promotional support for the Promus Premier Stent System in U.S. hospitals beginning January 1, 2014.